Implementation of statistical features of a Bayesian two-armed responsive adaptive randomization trial with post hoc analysis of time trend drift.

Bibliographic Details
Title: Implementation of statistical features of a Bayesian two-armed responsive adaptive randomization trial with post hoc analysis of time trend drift.
Authors: Shergina, Elena1 (AUTHOR), Richter, Kimber P.1 (AUTHOR), Zhang, Chuanwu1,2 (AUTHOR), Mussulman, Laura1 (AUTHOR), Nazir, Niaman1 (AUTHOR), Gajewski, Byron J.1 (AUTHOR) bgajewski@kumc.edu
Source: Journal of Biopharmaceutical Statistics. Jun2024, p1-15. 15p. 7 Illustrations, 3 Charts.
Abstract: Bayesian adaptive designs with response adaptive randomization (RAR) have the potential to benefit more participants in a clinical trial. While there are many papers that describe RAR designs and results, there is a scarcity of works reporting the details of RAR implementation from a statistical point exclusively. In this paper, we introduce the statistical methodology and implementation of the trial Changing the Default (CTD). CTD is a single-center prospective RAR comparative effectiveness trial to compare opt-in to opt-out tobacco treatment approaches for hospitalized patients. The design assumed an uninformative prior, conservative initial allocation ratio, and a higher threshold for stopping for success to protect results from statistical bias. A particular emerging concern of RAR designs is the possibility that time trends will occur during the implementation of a trial. If there is a time trend and the analytic plan does not prespecify an appropriate model, this could lead to a biased trial. Adjustment for time trend was not pre-specified in CTD, but post hoc time-adjusted analysis showed no presence of influential drift. This trial was an example of a successful two-armed confirmatory trial with a Bayesian adaptive design using response adaptive randomization. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Biopharmaceutical Statistics is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Business Source Complete
More Details
ISSN:10543406
DOI:10.1080/10543406.2024.2359149
Published in:Journal of Biopharmaceutical Statistics
Language:English